PT  - JOURNAL ARTICLE
ED  - Richter, Dominique
TI  - Aliskiren-Based Therapy Controls Blood Pressure Regardless of Plasma Renin Activity
DP  - 2010 Nov 01
TA  - MD Conference Express
PG  - 7--7
VI  - 10
IP  - 5
4099  - http://mdc.sagepub.com/content/10/5/7.1.short
4100  - http://mdc.sagepub.com/content/10/5/7.1.full
AB  - Although aliskiren is established as an effective antihypertensive agent, it is not known whether its BP-lowering effects are dependent on baseline plasma renin activity (PRA) levels. The current prospective, open-label trial was defined to evaluate the ability of aliskiren to control BP alone and in combination with other antihypertensive medications in patients with various baseline PRA levels.